HAYWARD, Calif., Aug. 31, 2011 /PRNewswire/ -- Solta Medical, Inc.
(Nasdaq: SLTM), the pioneer in fractional resurfacing and
non-invasive skin tightening and a global market leader in
aesthetic skin treatments, today, announced Health Canada approval
of its new Clear + Brilliant laser aesthetic treatment. This
technology is now available to physicians in Canada. In May of 2011, the company
received FDA 510(K) clearance and CE Mark to market and sell Clear
+ Brilliant. This revolutionary treatment is an effective
treatment based on fractional laser technology that is performed in
a professional setting.
The launch of Clear + Brilliant creates and defines an entirely
new category of laser aesthetic treatments designed to attract
younger patients looking to take control of their aging process.
Clear + Brilliant provides a new offering for physicians and skin
care providers to address evolving consumer needs and expand their
patient base. In-depth research with patients and their skin care
providers revealed an unmet need in the skin care continuum that
lies between over the counter or spa treatments and more aggressive
laser offerings such as Fraxel. These consumers would like a
more efficacious treatment than their current regimens, but as of
yet they do not need the full transformative benefits of a more
aggressive laser skin resurfacing procedure. They are looking
for a treatment solution that refreshes their skin, providing a
more youthful appearance.
Unlike other conventional lasers that utilize the stamping
delivery method, Clear + Brilliant features a patented Intelligent
Optical Tracking System that provides consistent coverage and
insures a uniformly toned treatment area. Each treatment
rejuvenates the skin from the inside out by allowing healthy,
younger-looking skin to surface and only takes about 20 minutes per
treatment session.
"Solta Medical is committed to strengthening our product
portfolio and meeting the needs of skin care professionals and
their patients," said Stephen J.
Fanning, Chairman of the Board, President and CEO of Solta
Medical, Inc. "With the Health Canada approval of our Clear +
Brilliant system and worldwide distribution of this product, we are
able to reach a whole new professional and consumer base. We
are excited to see this product expand our patient base and
generate incremental revenue for clinicians and for the
Company."
ABOUT SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a range of
skin issues under the industry's five premier brands: Thermage®,
Fraxel®, Isolaz®, CLARO® and Clear + Brilliant®. Thermage is an
innovative, non-invasive radiofrequency procedure for tightening
and contouring skin. As the leader in fractional laser technology,
Fraxel delivers minimally invasive clinical solutions to resurface
aging and sun damaged skin. Isolaz was the first laser or light
based system indicated for the treatment of inflammatory acne,
comedonal acne, pustular acne, and mild-to-moderate inflammatory
acne. CLARO is a personal care acne system that is the first FDA
cleared over-the-counter IPL device that uses a powerful
combination of both heat and light to clear skin quickly and
naturally. Clear + Brilliant is a unique, cost-effective treatment
that utilizes safe, fractional laser technology to correct and
prevent early signs of aging and is FDA cleared and CE marked.
Since 2002, approximately one million Thermage, Fraxel and Isolaz
procedures have been performed in over 100 countries. For more
information about Solta Medical, call 1-877-782-2286 or log on to
www.Solta.com.
© 2010 Solta Medical, Inc. All rights
reserved. Thermage, Fraxel, Isolaz, Clear+Brilliant, and Solta
Medical are trademarks or registered trademarks of Solta Medical,
Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.